Pro- and Anti-Inflammatory Cytokine Balance in Major Depression: Effect of Sertraline Therapy
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
The specific associations between antidepressant treatment and alterations in the levels of cytokines remain to be elucidated. In this study, we aimed to explore the role of IL-2, IL-4, IL-12, TNF-α, TGF-β1, and MCP-1 in major depression and to investigate the effects of sertraline therapy. Cytokine and chemokine levels were measured at the time of admission and 8 weeks after sertraline treatment. Our results suggest that the proinflammatory cytokines (IL-2, IL-12, and TNF-α) and MCP-1 were significantly higher, whereas anti-inflammatory cytokines IL-4 and TGF-β1 were significantly lower in patients with major depression than those of healthy controls. It seems likely that the sertraline therapy might have exerted immunomodulatory effects through a decrease in the proinflammatory cytokine IL-12 and an increase in the anti-inflammatory cytokines IL-4 and TGF-β1. In conclusion, our results indicate that Th1-, Th2-, and Th3-type cytokines are altered in the depressed patients and some of them might have been corrected by sertraline treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fluoxetine, paroxetine, venlafaxine, and sertraline have been shown to have the potential to increase the levels of TGF-β1, which may contribute to their antidepressant effects. 391 , 392”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [392]
Experimental — accuracy not yet measuredIn the citing paper
“Sutcigil et al. found elevated serum levels of IL-12, which decreased after eight weeks of sertraline therapy [120].”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [120]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Delves, P. J., & Roitt, I. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007063430107 · Cited by 1,666
Evidence for an immune response in major depression: A review and hypothesis
Maes, M. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00101-m · Cited by 1,003
Cytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735
Maes, M., Meltzer, H. Y., Bosmans, E., Bergmans, R., Vandoolaeghe, E., Ranjan, R., & Desnyder, R. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00028-l · Cited by 622
Depression, stress and immunological activation: The role of cytokines in depressive disorders
Connor, T. J., & Leonard, B. E. (1998) · Life Sciences · doi:10.1016/s0024-3205(97)00990-9 · Cited by 482
Tuglu, C., Kara, S. H., Caliyurt, O., Vardar, E., & Abay, E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1566-z · Cited by 391
Licinio, J., & Wong, M.-L. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000586 · Cited by 380
Th1, Th2, and Th3 cytokine alterations in major depression
MYINT, A., LEONARD, B., STEINBUSCH, H., & KIM, Y. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.07.008 · Cited by 371
Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.8.1189 · Cited by 364
Kubera, M., Lin, A.-H., Kenis, G., Bosmans, E., van Bockstaele, D., & Maes, M. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00012 · Cited by 343
Cited by
Items 101–200 of 323
Blood–brain barrier dysfunction in brain diseases: Clinical experience
Schoknecht, K., & Shalev, H. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03697.x · Cited by 73
Altered Chemokine Levels in the Cerebrospinal Fluid and Plasma of Suicide Attempters
Janelidze, S., Ventorp, F., Erhardt, S., Hansson, O., Minthon, L., Flax, J., Samuelsson, M., Traskman-Bendz, L., & Brundin, L. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.09.010 · Cited by 69
“In contrast, two earlier reports had shown increased blood levels of MCP-1 and eotaxin-1 in depressed patients (Sutcigil et al., 2007; Simon et al., 2008).”
ResultTombácz, D., Maróti, Z., Kalmár, T., Csabai, Z., Balázs, Z., Takahashi, S., Palkovits, M., Snyder, M., & Boldogkői, Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-06522-3 · Cited by 65
Microglial Cells as a Link between Cannabinoids and the Immune Hypothesis of Psychiatric Disorders
Lisboa, S. F. D. S., Gomes, F. V., Guimarães, F. S., & Campos, A. C. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00005 · Cited by 77
Spanemberg, L., Caldieraro, M., Arrua Vares, E., Wollenhaupt de Aguiar, B., Yuri Kawamoto, S., Parker, G., Pio Fleck, M., Kauer-SantAnna, M., & Galvao, E. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s66504 · Cited by 66
Gharekhani, A., Khatami, M., Dashti‐Khavidaki, S., Razeghi, E., Noorbala, A.-A., Nazari, S. S. H., & Mansournia, M. A. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-014-1666-1 · Cited by 72
Guerrera, C. S., Furneri, G., Grasso, M., Caruso, G., Castellano, S., Drago, F., Di Nuovo, S., & Caraci, F. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.00857 · Cited by 58
Neuroinflammation and Post-Stroke Depression: Focus on the Microglia and Astrocytes
Lu, W., & Wen, J. (2025) · Aging and disease · doi:10.14336/ad.2024.0214-1 · Cited by 54
Elomaa, A.-P., Niskanen, L., Herzig, K.-H., Viinamäki, H., Hintikka, J., Koivumaa-Honkanen, H., Honkalampi, K., Valkonen-Korhonen, M., Harvima, I. T., & Lehto, S. M. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-2 · Cited by 62
Wen, J., Chen, C. H., Stock, A. D., Doerner, J., Gulinello, M. E., & Putterman, C. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.12.017 · Cited by 65
Pérez-Sánchez, G., Becerril-Villanueva, E., Arreola, R., Martínez-Levy, G., Hernández-Gutiérrez, M. E., Velasco-Velásquez, M. A., Alvarez-Herrera, S., Cruz-Fuentes, C., Palacios, L., de la Peña, F., et al. (2018) · Mediators of Inflammation · doi:10.1155/2018/4074051 · Cited by 61
Molecular Basis of Late-Life Depression
Kuo, C.-Y., Lin, C., & Lane, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147421 · Cited by 67
Further studies on anti-inflammatory activity of maprotiline in carrageenan-induced paw edema in rat
Sadeghi, H., Hajhashemi, V., Minaiyan, M., Movahedian, A., & Talebi, A. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.01.018 · Cited by 66
Molecular Neurobiology and Promising New Treatment in Depression
Jeon, S. R., & Kim, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030381 · Cited by 73
Riveros, M. E., Ávila, A., Schruers, K. R. J., & Ezquer, F. E. (2022) · Antioxidants · doi:10.3390/antiox11030540 · Cited by 66
Bruenig, D., Mehta, D., Morris, C. P., Harvey, W., Lawford, B. R., Young, R. M., & Voisey, J. (2017) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2017.01.015 · Cited by 64
Caraci, F., Tascedda, F., Merlo, S., Benatti, C., Spampinato, S. F., Munafò, A., Leggio, G. M., Nicoletti, F., Brunello, N., Drago, F., et al. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00389 · Cited by 58
Impact of Stress on Epilepsy: Focus on Neuroinflammation—A Mini Review
Espinosa‐García, C., Zeleke, H., & Rojas, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084061 · Cited by 68
Immunotherapy for depression: Recent insights and future targets
Bai, Y., Cai, Y., Chang, D., Li, D., Huo, X., & Zhu, T. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108624 · Cited by 58
Novel investigational drugs targeting IL-6 signaling for the treatment of depression
Fonseka, T. M., McIntyre, R. S., Soczynska, J. K., & Kennedy, S. H. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.998334 · Cited by 54
Modulation of neuroimmune cytokine networks by antidepressants: implications in mood regulation
Nava, R. G., Adri, A. S., Filgueiras, I. S., Nóbile, A. L., Barcelos, P. M., Corrêa, Y. L. G., de Oliveira, S. F., Cabral‐Miranda, G., Dias, H. D., Schimke, L. F., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03532-y · Cited by 57
Alboni, S., Benatti, C., Montanari, C., Tascedda, F., & Brunello, N. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.08.046 · Cited by 53
Trojan, E., Ślusarczyk, J., Chamera, K., Kotarska, K., Głombik, K., Kubera, M., & Basta-Kaim, A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00779 · Cited by 52
Jonsdottir, I. H., Hägg, D. A., Glise, K., & Ekman, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007659 · Cited by 54
Milrad, S. F., Hall, D. L., Jutagir, D. R., Lattie, E. G., Czaja, S. J., Perdomo, D. M., FLETCHER, M. A., Klimas, N. G., & Antoni, M. H. (2017) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2017.09.009 · Cited by 55
Caraci, F., Bosco, P., Signorelli, M. S., Spada, R. S., Cosentino, F., Toscano, G., Bonforte, C., Muratore, S., Prestianni, G., Panerai, S., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.08.006 · Cited by 56
Neuroimmune endocrine effects of antidepressants
Carvalho, L. (2012) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s16409 · Cited by 53
Inflamed brain: Targeting immune changes and inflammation for treatment of depression
Sakamoto, S., Zhu, X., Hasegawa, Y., Karma, S., Obayashi, M., Alway, E., & Kamiya, A. (2021) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13286 · Cited by 51
Sahin, C., Albayrak, O., Akdeniz, T. F., Akbulut, Z., Yanikkaya Demirel, G., & Aricioglu, F. (2016) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12604 · Cited by 50
Bupropion pre-treatment of endotoxin-induced depressive symptoms
DellaGioia, N., Devine, L., Pittman, B. P., & Hannestad, J. O. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.10.008 · Cited by 51
Nelson, T. E., Hao, C., Manos, J., Ransohoff, R. M., & Gruol, D. L. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.02.013 · Cited by 47
van Heesch, F., Prins, J., Konsman, J. P., Westphal, K. G. C., Olivier, B., Kraneveld, A. D., & Korte, S. M. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.12.013 · Cited by 53
Resolution of inflammation and mood disorders
Chistyakov, D. V., Astakhova, A. A., & Sergeeva, M. G. (2018) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2018.08.002 · Cited by 74
Grygiel‐Górniak, B., Limphaibool, N., & Puszczewicz, M. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12826 · Cited by 49
Mirtazapine Inhibits Tumor Growth via Immune Response and Serotonergic System
Fang, C., Chen, H., Chiang, I., Chen, C.-C., Liao, J.-F., Su, T.-P., Chieh-Yin, T., Uchitomi, Y., & Hwang, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038886 · Cited by 51
Targeting the CCL2-CCR2 Axis in Depressive Disorders
Curzytek, K., & Leśkiewicz, M. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00280-w · Cited by 47
Effects of fluoxetine and escitalopram on C-reactive protein in patients of depression
Chavda, N., & Kantharia, N. D. (2011) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.77091 · Cited by 45
Wang, Q., Dong, X., Wang, Y., Liu, M., Sun, A., Li, N., lin, Y., Geng, Z., Jin, Y., & Li, X. (2017) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2017.07.007 · Cited by 46
Egeberg, A., Khalid, U., Gislason, G., Mallbris, L., Skov, L., & Hansen, P. R. (2015) · Acta Dermato Venereologica · doi:10.2340/00015555-2218 · Cited by 52
Küçükşahin, O., Omma, A., Özdemirel, A. E., Tecer, D., kandil, S. U., Maraş, Y., Balkarlı, A., & Erten, Ş. (2017) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13104 · Cited by 46
Immunomodulatory Effect of Sertraline in a Rat Model of Rheumatoid Arthritis
Baharav, E., Bar, M., Taler, M., Gil‐Ad, I., Karp, L., Weinberger, A., & Weizman, A. (2012) · NeuroImmunoModulation · doi:10.1159/000339109 · Cited by 46
Lymphocytes in neuroprotection, cognition and emotion: Is intolerance really the answer?
Rook, G. A. W., Lowry, C. A., & Raison, C. L. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.12.005 · Cited by 53
Trojan, E., Bryniarska, N., Leśkiewicz, M., Regulska, M., Chamera, K., Szuster-Głuszczak, M., Leopoldo, M., Lacivita, E., & Basta‐Kaim, A. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191019170244 · Cited by 44
Investigating the epigenetic profile of the inflammatory gene IL-6 in late-life depression
Ryan, J., Pilkington, L., Neuhaus, K., Ritchie, K., Ancelin, M.-L., & Saffery, R. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1515-8 · Cited by 40
Li, Z., Wang, Z., Zhang, C., Chen, J., Su, Y., Huang, J., Yi, Z., Yuan, C., Hong, W., Wang, Y., et al. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.03.015 · Cited by 41
Bosco, P., Ferri, R., Grazia Salluzzo, M., Castellano, S., Signorelli, M., Nicoletti, F., Di Nuovo, S., Drago, F., & Caraci, F. (2013) · Current Genomics · doi:10.2174/1389202911314020007 · Cited by 40
Peripheral Inflammatory Markers in Subtypes and Core Features of Depression: A Systematized Review
Křenek, P., Hořínková, J., & Bartečků, E. (2023) · Psychopathology · doi:10.1159/000528907 · Cited by 40
The Neuro‐Immune Axis: Prospect for Novel Treatments for Mental Disorders
Kraneveld, A. D., de Theije, C. G. M., van Heesch, F., Borre, Y., de Kivit, S., Olivier, B., Korte, M., & Garssen, J. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12154 · Cited by 37
A Potential Contribution of Chemokine Network Dysfunction to the Depressive Disorders
|lusarczyk, J., Trojan, E., Chwastek, J., G|ombik, K., & Basta-Kaim, A. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160219131357 · Cited by 37
Pandey, G. N., Rizavi, H. S., Bhaumik, R., & Zhang, H. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.01.033 · Cited by 38
The influence of mianserin on TNF-α, IL-6 and IL-10 serum levels in rats under chronic mild stress
Manikowska, K., Mikołajczyk, M., Mikołajczak, P. Ł., & Bobkiewicz-Kozłowska, T. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2013.06.003 · Cited by 39
Inflammation is associated with future depressive symptoms among older adults
Bondy, E., Norton, S. A., Voss, M., Marks, R. B., Boudreaux, M. J., Treadway, M. T., Oltmanns, T. F., & Bogdan, R. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100226 · Cited by 38
Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
Myung, W., Lim, S.-W., Woo, H. I., Park, J. H., Shim, S., Lee, S.-Y., & Kim, D. K. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.6.644 · Cited by 33
Prince, N., Marzal, L. N. P., Markidi, A., Ahmed, S., Adolfs, Y., Pasterkamp, R. J., Kumar, H., Roeselers, G., Garssen, J., Kraneveld, A. D., et al. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01268-x · Cited by 33
Ma, Y., Balasubramanian, R., Pagoto, S. L., Schneider, K. L., Hébert, J. R., Phillips, L. S., Goveas, J. S., Culver, A. L., Olendzki, B. C., Beck, J., et al. (2013) · American Journal of Public Health · doi:10.2105/ajph.2013.301394 · Cited by 29
Targeting the renin angiotensin system for the treatment of anxiety and depression
Chrissobolis, S., Luu, A. N., Waldschmidt, R. A., Yoakum, M. E., & D’Souza, M. S. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.173063 · Cited by 37
Serum IL-7 and G-CSF in major depressive disorder
Lehto, S. M., Huotari, A., NISKANEN, L. K., Herzig, K., Tolmunen, T., Viinamäki, H. T., Koivumaa-Honkanen, H. T., Honkalampi, K. M., Sinikallio, S., Ruotsalainen, H. J., et al. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.03.033 · Cited by 36
Zong, Y., Xue, Y., Zhao, Y., Ding, H., He, D., Li, Z., Tang, Y., & Wang, Y. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1714-8 · Cited by 34
Munsterhjelm, C., Nordgreen, J., Aae, F., Heinonen, M., Olstad, K., Aasmundstad, T., Janczak, A. M., & Valros, A. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.06.024 · Cited by 36
Ogłodek, E. A. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.08.008 · Cited by 32
Hu, S. C., Chen, G., & Tu, H. (2019) · Acta Dermato Venereologica · doi:10.2340/00015555-3145 · Cited by 32
Białek, K. I., Czarny, P. L., Watała, C. W., Wigner, P., Talarowska, M. E., Gałecki, P., Szemraj, J., & Śliwiński, T. (2020) · PeerJ · doi:10.7717/peerj.8676 · Cited by 32
Einvik, G., Vistnes, M., Hrubos‐Strøm, H., Randby, A., Namtvedt, S. K., Nordhus, I. H., Somers, V. K., Dammen, T., & Omland, T. (2012) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2012.01.017 · Cited by 34
Al‐Hakeim, H. K., Twayej, A. J., Al-Dujaili, A. H., & Maes, M. H. J. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200102100307 · Cited by 31
Effect of diclofenac and antidepressants on the inflammatory response in astrocyte cell culture
Al-Amin, M. M., Uddin, M. M. N., Rahman, M. M., Reza, H. M., & Rana, M. S. (2013) · Inflammopharmacology · doi:10.1007/s10787-013-0181-9 · Cited by 30
Inamdar, A., Pich, E. M., Gee, M., Makumi, C. W., Mistry, P. C., Robertson, J., Steinberg, E., Zamuner, S., Learned, S. M., Alexander, R., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114529377 · Cited by 32
Wu, X., Tang, B.-Q., Liao, X., Su, Z., Lee, S. M., Cai, Y., & Li, C. (2019) · Food & Function · doi:10.1039/c8fo02474j · Cited by 31
Depression and Anxiety in Rosacea Patients: A Systematic Review and Meta-Analysis
Dai, R., Lin, B., Zhang, X., Lou, Y., & Xu, S. (2021) · Dermatology and Therapy · doi:10.1007/s13555-021-00613-w · Cited by 30
Roomruangwong, C., Sirivichayakul, S., Carvalho, A. F., & Maes, M. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.033 · Cited by 29
van Belkum, S. M., Bosker, F. J., Kortekaas, R., Beersma, D. G. M., & Schoevers, R. A. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.07.006 · Cited by 29
“tokines (TH1) and anti-inflammatory cytokines (TH2 and TH3) might be particularly important (Kim et al., 2007; Sutcigil et al., 2007).”
Neuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets
Herman, F. J., Simkovic, S. J., & Pasinetti, G. M. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14569 · Cited by 29
Afridi, R., Seol, S., Kang, H. J., & Suk, K. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114532 · Cited by 29
Liu, Y., Hui, F., Mo, Y., Jingfang, G., Hongjing, M., Mingfen, S., Shengdong, W., Yan, Y., & Wenjuan, L. (2015) · 中医杂志:英文版 · doi:10.1016/s0254-6272(15)30132-1 · Cited by 31
Use of Sertraline in Hemodialysis Patients
Kubanek, A., Paul, P., Przybylak, M., Kanclerz, K., Rojek, J. J., Renke, M., Bidzan, L., & Grabowski, J. (2021) · Medicina · doi:10.3390/medicina57090949 · Cited by 32
Somatic Drugs for Psychiatric Diseases: Aspirin or Simvastatin for Depression?
Rahola, J. G. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604533 · Cited by 32
Rosas-Sánchez, G. U., Germán-Ponciano, L. J., Puga-Olguín, A., Flores-Soto, M. E., Nápoles-Medina, A. Y., Muñoz‐Carrillo, J. L., Rodríguez‐Landa, J. F., & Soria-Fregozo, C. (2025) · Biomedicines · doi:10.3390/biomedicines13081831 · Cited by 33
Naeini, F. B., Hassanpour, S., & Asghari, A. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114201 · Cited by 28
The neurodegenerative hypothesis of depression and the influence of antidepressant medications
Hall, S., Parr, B.-A., Hussey, S., Anoopkumar‐Dukie, S., Arora, D. S., & Grant, G. D. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176967 · Cited by 27
Abnormalities of lipid metabolism in the progression and treatment of depression
Luan, X., Wang, X., Shi, Y., Zhang, X., Wang, Y., Zhou, M., Wu, Z., Liu, Z., Li, X., Zhang, L., et al. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1589663 · Cited by 30
Association of depression with inflammation in hospitalized patients of myocardial Infarction
Shang, Y.-X., Ding, W., Qiu, H., Dong, G.-Q., Zhu, F., Yan, S.-Z., & Wang, X.-L. (2014) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.304.4584 · Cited by 27
Ardakani, M. T., Mehrpooya, M., Mehdizadeh, M., Beiraghi, N., Hajifathali, A., & Kazemi, M. H. (2019) · Bone Marrow Transplantation · doi:10.1038/s41409-019-0623-0 · Cited by 26
Chang, L., Wei, Y., Qu, Y., Zhao, M., Zhou, X., Long, Y., & Hashimoto, K. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106573 · Cited by 27
Impact of sertraline on serum concentration of CRP in hemodialysis patients with depression
Zahed, N. S., Sharifi, M., Karimi, M., & Nikbakht, H. (2016) · Journal of Renal Injury Prevention · doi:10.15171/jrip.2017.12 · Cited by 28
Hyperforin improves post-stroke social isolation‑induced exaggeration of PSD and PSA via TGF-β
Zhang, Y., Yu, P., Liu, H. Q., Yao, H., Yao, S., Yuan, S., & Zhang, J. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3971 · Cited by 31
Proteomic analysis of rat hippocampus exposed to the antidepressant paroxetine
McHugh, P., Rogers, G., Glubb, D., Joyce, P., & Kennedy, M. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109102786 · Cited by 25
Funatsuki, T., Ogata, H., Tahara, H., Shimamoto, A., Takekita, Y., Koshikawa, Y., Nonen, S., Higasa, K., Kinoshita, T., & Kato, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512199 · Cited by 25
Sarmin, N., Roknuzzaman, A. S. M., Mouree, T. Z., Islam, M. R., & Mahmud, Z. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-51932-9 · Cited by 27
Converged avenues: depression and Alzheimer’s disease– shared pathophysiology and novel therapeutics
Bajaj, S., & Mahesh, R. (2024) · Molecular Biology Reports · doi:10.1007/s11033-023-09170-1 · Cited by 28
Peng, Z., Xue, Y., Wang, H., Wang, H., Xue, F., Kuang, F., Wang, B., Chen, Y., Zhang, L.-Y., & Tan, Q. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.08.014 · Cited by 27
Han, Y., Sun, C.-Y., Meng, S., Tabarak, S., Yuan, K., Cao, L., Yan, W., Xu, L., Deng, J., Zhu, W., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0470-9 · Cited by 27
Sinikallio, S., Lehto, S. M., Aalto, T. J., Airaksinen, O., Kröger, H., & Viinamäki, H. T. (2010) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-11-152 · Cited by 25
Serum levels of chemokines in adolescents with major depression treated with fluoxetine.
Peña, F. R. D. L., Cruz-Fuentes, C., Palacios, L., Girón-Pérez, M. I., Medina-Rivero, E., Ponce-Regalado, M. D., Alvarez-Herrera, S., Pérez-Sánchez, G., Becerril-Villanueva, E., Maldonado-García, J. L., et al. (2020) · World Journal of Psychiatry · doi:10.5498/wjp.v10.i8.175 · Cited by 24
Coín‐Aragüez, L., Pavón, F. J., Contreras, A., Gentile, A., Lhamyani, S., de Diego‐Otero, Y., Casado, Y., Oliva‐Olivera, W., Olveira, G., Tinahones, F. J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35759-9 · Cited by 24
Sundquist, K., Memon, A. A., Palmér, K., Sundquist, J., & Wang, X. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155646 · Cited by 25
Fernandes, B. M., Scotti-Muzzi, E., & Soeiro‐de‐Souza, M. G. (2021) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-021-03240-8 · Cited by 26
Reduced MIP-1β as a Trait Marker and Reduced IL-7 and IL-12 as State Markers of Anorexia Nervosa
Keeler, J. L., Patsalos, O., Chung, R., Schmidt, U. H., Breen, G. D., Treasure, J. L., Himmerich, H., & Dalton, B. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080814 · Cited by 26
Qiu, A., Zhang, H., Wang, C., Chong, Y.-S., Shek, L. P., Gluckman, P. D., Meaney, M. J., Fortier, M. V., & Wu, Y. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01292-z · Cited by 23
Gędek, A., Modrzejewski, S., Materna, M., Iwański, M., Wichniak, A., & Dominiak, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110362 · Cited by 27
Pethő, B., Kovács, M. Á., Simon, D., Tóth, T., Hajnal, A. S., Csulak, T., Hebling, D., Albert, N., Varga, E., Herold, M., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1321354 · Cited by 24
Kostadinov, I., Delev, D. P., Petrova, A., Stanimirova, I., Draganova, K., Kostadinova, I. I., & Murdjeva, M. (2014) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2014.932136 · Cited by 25
Metadata
- Authors
- Sutcigil, L., Oktenli, C., Musabak, U., Bozkurt, A., Cansever, A., Uzun, O., Sanisoglu, S. Y., Yesilova, Z., Ozmenler, N., Ozsahin, A., & Sengul, A.
- Affiliations
- Gülhane Askerî Tıp Akademisi (TR)
- Venue
- Clinical and Developmental Immunology
- Publisher
- Hindawi Limited
- Published
- 2007
- Volume
- 2007
- Pages
- 1-6
- ISSN
- 1740-2522 (ISSN-L)
- 1740-2530
- PMC
- PMC2248234
- OpenAlex
- W1998520631
- Cited by
- 315
- References
- 36
- Citations by year
- 2026: 2 · 2025: 15 · 2024: 19 · 2023: 13 · 2022: 9 · 2021: 26 · 2020: 24 · 2019: 16 · 2018: 14 · 2017: 21 · 2016: 28 · 2015: 11 · 2014: 28 · 2013: 17 · 2012: 16
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Clinical and Developmental Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- AYBU AVESIS (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Gülhane Military Medical Academy
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- major depressive disorder, sertraline, cytokines, chemokines, inflammatory cytokines, anti-inflammatory cytokines, IL-12, IL-4, TNF-α, TGF-β1, MCP-1, immunomodulation, antidepressant effects, Th1/Th2 balance
- MeSH terms
- Adult, Antidepressive Agents, Major Depressive Disorder, Depressive Disorder, Major, Enzyme-Linked Immunosorbent Assay, Female, Humans, Interleukin-2, Male, Tumor Necrosis Factor-alpha, Interleukin-4, Cytokines, Interleukin-12, Chemokine CCL2, Sertraline, Transforming Growth Factor beta1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.